| 查看: 1126 | 回复: 16 | |||
| 【奖励】 本帖被评价8次，作者msd2phd增加金币 7 个 | |||
| 当前主题已经存档。 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[资源]
Chirality in Drug Research
|
|||
|
Chirality in Drug Research (Methods and Principles in Medicinal Chemistry) # Publisher: Wiley-VCH # Number Of Pages: 370 # Publication Date: 2007-01-02 Divided into the three main sections of synthesis, analysis and drug development, this handbook covers all stages of the drug development process, including large-scale synthesis and purification of chirally pure pharmaceuticals. The two editors from academia and a major pharmaceutical company have assembled an experienced, international team who provide first-hand practical advice and report previously unpublished data. In the first section, the isolation of chiral drugs from natural sources, their production in enzymatic processes and the resolution of racemic mixtures in preparative chromatography are outlined in separate chapters. For the section on qualitative and quantitative analysis, enantioselective chromatographic methods are presented as well as optical methods and CE-MS, while the final section deals with the pharmacology, pharmacokinetics and metabolic aspects of chiral drugs, devoting whole chapters to stereoselective drug binding and modeling chiral drug-receptor interactions. With its unique industry-relevant aspects, this is a must for medicinal and pharmaceutical chemists. [ Last edited by msd2phd on 2007-11-20 at 20:41 ] |
回复此楼» 猜你喜欢
关于filecode，很负责任的告诉大家
已经有7人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
关于豆爷回答的JTJC与%2F数量
已经有7人回复
-
2026国自然放榜时间
已经有3人回复
-
国基金的申报应该改成非等额制，评价高的钱多评价低的钱少，但是增加资助率
已经有7人回复
-
好奇怪的filecode
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O54,科目全,可伽急
已经有4人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.54,科目齐全,可+急
已经有5人回复
|
谢谢共享 我做了一个Rapidshare 空间下载图解教程，不知道这么下载的朋友可以到那里学习 http://muchong.com/bbs/viewthread.php?tid=591515&fpage=1 |
5楼2007-10-06 19:41:54
4楼2007-10-06 13:08:08
7楼2007-11-04 06:37:08
8楼2007-11-17 04:19:27
简单回复
msd2phd2楼
2007-10-02 12:20
回复
